文献速递类风湿关节炎其他结缔组织病

靶向表达LRRC15的成纤维细胞可减轻自身免疫病炎症与纤维化

Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究通过转录组学分析、流式细胞术、RNA-seq、免疫组化及空间转录组学,在类风湿关节炎(RA)和系统性硬化症(SSc)中表征LRRC15在成纤维细胞亚群中的表达,并评估靶向LRRC15阳性成纤维细胞对纤维化和成纤维细胞介导炎症的治疗潜力。结果显示RA滑膜和SSc皮肤中活化成纤维细胞基因特征与Lrrc15表达相关,LRRC15阳性成纤维细胞聚集于RA滑膜三级淋巴结构(TLS),敲低Lrrc15可减少TNF-α诱导的炎症趋化因子产生,且高表达LRRC15的炎症成纤维细胞易被NK细胞特异性裂解。结论提示靶向LRRC15阳性成纤维细胞及纤维化微环境可能为RA、SSc等自身免疫病提供新治疗机会。

要点

  • RA滑膜和SSc皮肤中活化成纤维细胞基因特征与Lrrc15表达升高相关。
  • LRRC15阳性成纤维细胞聚集于RA滑膜三级淋巴结构(TLS)内。
  • 敲低Lrrc15减少TNF-α诱导的CCL3和CXCL10产生,高表达LRRC15的炎症成纤维细胞可被NK细胞特异性裂解。

核心结论

  • 靶向LRRC15阳性成纤维细胞及纤维化微环境可能为减少RA、SSc及其他活化成纤维细胞参与发病的自身免疫病炎症提供新治疗机会。

研究设计与样本

  • 研究对RA和SSc的 bulk 及单细胞RNA-seq数据集进行Lrrc15转录组学分析。
  • 采用流式细胞术、RNA-seq、免疫组化和空间转录组学定义病变组织中Lrrc15表达模式。
  • 通过体外和体内实验阐明LRRC15在炎症成纤维细胞中的功能。

主要发现

  • 与健康对照相比,RA滑膜和SSc皮肤活检中活化成纤维细胞基因特征较高且与Lrrc15表达相关。
  • 多免疫荧光成像显示RA滑膜三级淋巴结构(TLS)内LRRC15阳性成纤维细胞聚集。
  • 在原代细胞中敲低Lrrc15减少TNF-α诱导的炎症趋化因子CCL3和CXCL10产生。
  • 在小鼠伤口愈合和肺纤维化模型中确认LRRC15上调。
  • 体外高表达LRRC15的炎症成纤维细胞易被NK细胞介导的LRRC15特异性裂解。

临床怎么用

  • 靶向LRRC15阳性成纤维细胞可能作为减轻RA和SSc炎症与纤维化的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Targeting stromal cells such as inflammatory fibroblasts presents a potential avenue to alleviate autoimmune inflammation and fibrosis. This study aimed to characterize LRRC15 expression in rheumatoid arthritis (RA) and systemic sclerosis (SSc) across fibroblast subsets and assess whether targeting LRRC15-expressing fibroblasts can be beneficial for the treatment of fibrosis and fibroblast-mediated inflammation. METHODS: We conducted transcriptomic analyses of Lrrc15 in bulk and single-cell RNA-seq datasets from RA and SSc. We used flow cytometry, RNA-seq, immunohistochemistry and spatial transcriptomics to define Lrrc15 expression patterns in diseased tissues. We performed in vitro and in vivo assays to elucidate the function of LRRC15 in inflammatory fibroblasts. RESULTS: When compared with healthy controls, we observed a higher activated fibroblast gene signature in RA synovium and SSc skin biopsies that correlated with Lrrc15 expression. Multi-IF imaging highlighted the clustering of LRRC15-expressing fibroblasts within tertiary lymphoid structures (TLS) in RA synovium. Knockdown of Lrrc15 in primary cells reduced production of TNF-α induced inflammatory chemokines including CCL3 and CXCL10. We confirmed LRRC15 upregulation in mouse models of wound healing and pulmonary fibrosis. Inflammatory fibroblasts with high LRRC15 expression were susceptible to NK cell-mediated LRRC15 specific lysis in vitro. CONCLUSION: Targeting LRRC15+ fibroblasts and fibrotic microenvironment may offer a new therapeutic opportunity to reduce inflammation in RA, SSc and other autoimmune disorders where activated fibroblasts play a role in disease pathogenesis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tu X, Bach TN, Baghela A, et al. Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases. Rheumatology (Oxford). 2026. PMID: 42340684. doi:10.1093/rheumatology/keag293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。